CH
SPRB

CVI Holdings’s Spruce Biosciences SPRB Stock Holding History

CVI Holdings’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,293
Closed -$1.04M – 306
2023
Q1 		$1.04M Buy
+6,293
New +$1.17M 0.39% 81

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CVI Holdings's SPRB Position: Q2 2023 in Review

CVI Holdings sold out of Spruce Biosciences (SPRB) in Q2 2023, closing a stake of 6,293 shares — an estimated $1.04M sold.

CVI Holdings first reported a position in SPRB in Q1 2023 and held it in 1 quarter. The position peaked at $1.04M in Q1 2023. 38 funds tracked by Wall St. Rank hold SPRB as of Q2 2023.

  • CVI Holdings reported no remaining Spruce Biosciences position as of Q2 2023 after selling out during the quarter.
  • CVI Holdings sold 6,293 Spruce Biosciences shares in Q2 2023, an estimated $1.04M.
  • CVI Holdings first reported a position in Spruce Biosciences in Q1 2023 and held it in 1 quarter.
  • CVI Holdings's Spruce Biosciences position peaked at $1.04M in Q1 2023.
  • 38 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.